The Infertility Treatment Market is Expected to Grow at a CAGR of Over 6% During the Forecast Period 2018-2024
Speak directly to the analyst to clarify any post sales queries you may have.
The growing prevalence of infertility among men and women is increasing the demand for sterility treatment globally. Factors such as delayed parenthood, obesity, sexually transmitted infections (STIs), and aging is increasing sterility incidences among married couples worldwide.
The increasing acceptance of advanced and sophisticated medical care options such as ART and IVF is likely to drive the market. The globalization of healthcare facilities and the increasing popularity of medical tourism, especially fertility tourism, encourage several couples to travel abroad to seek state-of-the-art medical care options. The reimbursement coverage is also improving globally, and many countries cover fertility treatment as part of respective public health coverage programs
The following factors are likely to contribute to the growth of the infertility treatment market during the forecast period:
- Increasing Prevalence of Infertility
- Growing Number of Obesity Cases
- Increasing Number of Facilities offering Fertility Services
- Increasing Financial Assistance Programs
- Growing popularity for Fertility Tourism
The study considers the present scenario of the global infertility treatment market and its market dynamics for the period 2018−2024. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market.
Infertility Treatment Market: Segmentation
This research report includes detailed segmentation by product, procedure, end-user, cause, and geography. Treatment by drugs has been dominating the infertility treatment market because it is a cost-effective measure and is considered to be the first choice among people to be treated. The acceptance of gonadotropin drugs for treatment is driving the segment significantly and is likely to witness steady growth during the forecast period. However, the surge in the prevalence of sterility, advances IVF devices technology, the increasing trend of delayed pregnancies, and the growth in disposable income are the major factors driving the infertility treatment devices market.
Globally, the IVF treatments are witnessing an improvement in overall success rates majorly due to the availability of a broad range of culture media. The consumables segment is rapidly increasing due to the increasing effectiveness of ART procedures and surgical interventions that create huge demand for consumables and is expected to grow by 2024.
The medication segment is the largest contributor due to a wide range and usage. The increasing approval of fertility services and cultural shifts has led to a high demand for medication and treatments. The awareness of sterility treatment has increased over time, thereby reducing the reluctance of people to opt for medication. ART is the fastest growing procedure on account of the high acceptance of this treatment because of the improvement in success rate and advanced techniques to cure sterility. The favorable financial support for ART procedures in both developed and emerging countries is another factor contributing to the growth. However, the segment is likely to witness hindrance due to the high cost of ART procedures.
The fertility clinics dominate the market due to the high success rate of fertility services and IVF clinics. The number of fertility services is expanding across the globe. These clinics occupy the largest share in the infertility treatment market owing to the availability and accessibility of different services such as IVF programs, egg donation, ICSI, IMSI, and other services. The segment is projected to hold the highest share during the forecast period due to the constant rise in clinics and increasing partnerships of clinics with fertile consultants and experts.
The female infertility segment is contributing significantly to the market due to the high prevalence of female infertility globally. The increase in the target pool of female patients and the growing number of dedicated fertility clinics are the major factors driving the growth of the segment. The prevalence of male sterility is increasing worldwide due to changes in lifestyle patterns, an increase in the consumption of alcohol and smoking, and an increase in the prevalence of obesity. All these factors affect sperm counts and their quality, thereby increasing the occurrence among men.
Market Segmentation by Product
- Drugs
- Gonadotropins
- Other Drugs
- Devices
- Equipment
- Media
- Consumables
Market Segmentation by Procedure
- Drug Therapy
- ART Procedure
- Surgical Intervention
Market Segmentation by End-user
- Infertility Clinics
- Hospitals
- Gynecological & Urology Clinics
- Others
Market Segmentation by Cause
- Female Infertility
- Male Infertility
- Others
Insights by Geography
Europe is the major region, which is leading the market and is expected to bolster its dominance during the forecast period because the region is going through a phase of reduction in population and is seriously considering tackling this sociological phenomenon. The demand for fertility services is increasing rapidly in North America due to the growing prevalence of sterility, the presence of the aging population and the high occurrence of obesity. These factors are likely to generate significant demand for fertility services in the future. APAC is growing at a steady pace owing to the shifting mean age among women during their first childbirth and the increasing sterility among people in developing countries. Latin America is witnessing a rise in sterility among men and women and decreasing fertility rates in the population, which is likely to increase the demand for fertility services. MEA faces a low healthcare facility, a lack of specialized health care professionals, and inadequate awareness of fertility medical care. However, with the growing awareness and development of advanced technology, the region is expected to drive the infertility treatment market in the region.
Market Segmentation by Geography
- Europe
- Spain
- France
- Germany
- UK
- Italy
- North America
- Canada
- US
- APAC
- China
- Japan
- South Korea
- India
- Australia
- Latin America
- Brazil
- Argentina
- Mexico
- MEA
- Turkey
- Israel
Insights by Vendors
There are a few global and several local and regional vendors offering medicines, devices, and equipment for treatment. The fertility drugs market is highly concentrated with key pharmaceuticals accounting for commendable shares. However, the other fertility drugs market is highly fragmented with many local and domestic companies are offering a wide array of low-cost drugs in their respective countries. The market is competitive due to the availability of several low-cost drugs. Companies offering fertility drugs are registering impressive growth rates for their products due to the increased uptake of these drugs.
Key Vendors
- The Cooper Companies
- Cook Medical
- Vitrolife
- Ferring Pharmaceuticals
- IVFtech
- Irvine Scientific
- Merck KGaA
Other Vendors
- Abbott
- Sanofi
- Salix Pharmaceuticals
- Microtech IVF
- Novartis
- Hamilton Thorne
- The Merck Co
- Thermo Fisher Scientific
- INVO Bioscience
- MedGyn Products
- SOMATEX Medical Technologies
- CARL ZEISS
Key Market Insights
- The analysis of the infertility treatment market provides sizing and growth opportunities for the forecast period 2019-2024.
- Provides comprehensive insights on the latest industry trends, forecast, and growth drivers in the market.
- Includes a detailed analysis of growth drivers, challenges, and investment opportunities.
- Delivers a complete overview of segments and the regional outlook of the infertility treatment market.
- Offers an exhaustive summary of the vendor landscape, competitive analysis, and key strategies to gain competitive advantage.
Table of Contents
1 Research Methodology2 Research Objectives3 Research Process
Samples
LOADING...
Companies Mentioned
- The Cooper Companies
- Cook Medical
- Vitrolife
- Ferring Pharmaceuticals
- IVFtech
- Irvine Scientific
- Merck KGaA
- Abbott
- Sanofi
- Salix Pharmaceuticals
- Microtech IVF
- Novartis
- Hamilton Thorne
- The Merck Co
- Thermo Fisher Scientific
- INVO Bioscience
- MedGyn Products
- SOMATEX Medical Technologies
- CARL ZEISS
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
